South & Central America Malaria Treatment Market Forecast to 2030

At 19.4% CAGR, South & Central America Malaria Treatment Market is Speculated to be Worth US$ 247.33 Million by 2030, says the Research Team

According to the Research Team research, the South & Central America malaria treatment market was valued at US$ 59.68 million in 2022 and is expected to reach US$ 247.33 million by 2030, registering a CAGR of 19.4% from 2022 to 2030. Extending pipeline of new drugs and vaccines and growing strategic initiatives are among the critical factors attributed to the South & Central America malaria treatment market expansion.

Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options. Therefore, the growing number of antimalarial and drugs/vaccines that are under clinical development are expected to boost the market growth in the future.

A few antimalarial that are under clinical development are mentioned in the table below:

Table 1. Malaria Drugs/Vaccine/Compounds Under Clinical Development

Drug Developer Clinical Trial Stage

Artefenomel Sanofi Phase IIb

KAE609 Novartis AG Phase IIb

KAF156 Novartis AG Phase IIb

DSM265 Takeda Pharmaceutical Company Phase IIa

SANARIA PfSPZ-GA1 Sanaria Phase II

SANARIA PfSPZ Vaccine – Radiation Attenuated PfSPZ Vaccine Sanaria Phase II

SANARIA PfSPZ-CVac Sanaria Phase II

MSP3-CRM-Vac4All Vac4All Phase I

Liver-Stage Antigen-3 (LSA3) Vac4All Phase IIa

Source: Company Website, the Research Team Analysis

Therefore, the growing number of antimalarial and drugs/vaccines that are under clinical development are expected to boost the market growth in the future.

On the contrary, availability of counterfeit antimalarial drugs followed by subsequent drug resistance hurdles the growth of South & Central America malaria treatment market.

Based on treatment, the South & Central America malaria treatment market is categorized into generic drugs, originators, vaccines, and others. The vaccines segment held 95.0% share of South & Central America malaria treatment market in 2022, amassing US$ 56.70 million. It is projected to garner US$ 236.77 million by 2030 to expand at 19.6% CAGR during 2022-2030.

In terms of route of administration, the South & Central America malaria treatment market is bifurcated into oral and parenteral. The oral segment held 69.7% share of South & Central America malaria treatment market in 2022, amassing US$ 41.57 million. It is projected to garner US$ 169.90 million by 2030 to expand at 19.2% CAGR during 2022-2030.

By distribution channel, the South & Central America malaria treatment market is categorized into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held 45.5% share of South & Central America malaria treatment market in 2022, amassing US$ 27.17 million. It is projected to garner US$ 113.01 million by 2030 to expand at 19.5% CAGR during 2022-2030.

Based on country, the South & Central America malaria treatment market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 86.4% share of South & Central America malaria treatment market in 2022. It was assessed at US$ 51.58 million in 2022 and is likely to hit US$ 214.78 million by 2030, exhibiting a CAGR of 19.5% during 2022-2030.

Key players operating in the South & Central America malaria treatment market are Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, and Lupin Ltd, among others.

In November 2022, Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria.

In October 2021, GSK welcomes WHO recommendation for broad roll-out of its RTS,S/AS01e (RTS,S) malaria vaccine.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America malaria treatment market
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America malaria treatment market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights – Malaria
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Malaria Treatment Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increasing Prevalence of Malaria
4.1.2 Rising Initiatives to Raise Awareness about Malaria
4.2 Market Restraints
4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
4.3 Market Opportunities
4.3.1 Growing Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Extending Pipeline of New Drugs and Vaccines
4.5 Impact Analysis
5. Malaria Treatment Market – South & Central America Market Analysis
5.1 South & Central America Malaria Treatment Market Revenue (US$ million), 2022 – 2030
6. South & Central America Malaria Treatment Market – Revenue and Forecast to 2030 – by Treatment
6.1 Overview
6.2 South & Central America Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
6.3 Vaccines
6.3.1 Overview
6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
6.4 Generic Drugs
6.4.1 Overview
6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
6.5 Originators
6.5.1 Overview
6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
6.6 Others
6.6.1 Overview
6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)
7. South & Central America Malaria Treatment Market – Revenue and Forecast to 2030 – by Route of Administration
7.1 Overview
7.2 South & Central America Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
7.3 Oral
7.3.1 Overview
7.3.2 Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Parenteral
7.4.1 Overview
7.4.2 Parenteral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Malaria Treatment Market – Revenue and Forecast to 2030 – by Distribution Channel
8.1 Overview
8.2 South & Central America Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Direct Tender
8.3.1 Overview
8.3.2 Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Hospital Pharmacies
8.4.1 Overview
8.4.2 Hospital Pharmacies: Malaria Market – Revenue and Forecast to 2030 (US$ Million)
8.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
8.5 Retail Pharmacies
8.5.1 Overview
8.5.2 Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
8.6 Online Pharmacies
8.6.1 Overview
8.6.2 Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Malaria Treatment Market – Country Analysis
9.1 South & Central America Malaria Treatment Market, Revenue and Forecast to 2030
9.1.1 Overview
9.1.1.1 South & Central America: Malaria Treatment Market, by Countries
9.1.1.2 Brazil
9.1.1.3 Overview
9.1.1.3.1 Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.2 Brazil: Malaria Treatment Market, by Treatment
9.1.1.3.3 Brazil: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.3.4 Brazil: Malaria Treatment Market, by Distribution Channel
9.1.1.3.4.1 Brazil: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.3.4.2 Brazil: Malaria Treatment Market, by Retail Pharmacies
9.1.1.4 Argentina
9.1.1.5 Overview
9.1.1.6 Rest of South & Central America
9.1.1.7 Overview
9.1.1.7.1 Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.7.2 Rest of South & Central America: Malaria Treatment Market, by Treatment
9.1.1.7.3 Rest of South & Central America: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.7.4 Rest of South & Central America: Malaria Treatment Market, by Distribution Channel
9.1.1.7.4.1 Rest of South & Central America: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.7.4.2 Rest of South & Central America: Malaria Treatment Market, by Retail Pharmacies
10. Malaria Treatment Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Malaria Treatment Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Cipla Ltd
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sun Pharmaceutical Industries Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sanofi SA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 GSK Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Novartis AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Pfizer Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Service
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Lupin Ltd
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms

Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Retail Pharmacies
Table 5. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 6. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 7. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 8. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 9. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 10. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 11. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 12. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 13. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 14. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 15. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 16. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 17. Glossary of Terms, Malaria Treatment Market
 

Figure 1. Malaria Treatment Market – Key Industry Dynamics
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Malaria Treatment Market Revenue (US$ million), 2022 – 2030
Figure 4. South & Central America Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 9. South & Central America Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 10. Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. South & Central America Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 13. Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hospital Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Malaria Treatment Market, 2022 ($Mn)
Figure 19. South & Central America: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
Figure 20. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Growth Strategies in the Malaria Treatment Market